You are here

  • Home
  • Archive
  • Volume 67, Issue 6
  • Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus

Article Text

Article menu
Download PDFPDF
Extended report
Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus
  1. S Jiménez1,
  2. D Tàssies2,
  3. G Espinosa1,
  4. Á García-Criado3,
  5. J Plaza1,
  6. J Monteagudo2,
  7. R Cervera1,
  8. J C Reverter2
  1. 1
    Department of Autoimmune Diseases, Institut Clínic de Medicina i Dermatologia, Hospital Clínic, Barcelona, Catalonia, Spain
  2. 2
    Department of Hemotherapy and Hemostasis, Centre de Diagnòstic Biomèdic, Hospital Clínic, Barcelona, Catalonia, Spain
  3. 3
    Department of Radiology, Centre de Diagnòstic per la Imatge, Hospital Clínic, Barcelona, Catalonia, Spain
  1. Ricard Cervera, Department of Autoimmune Diseases, Institut Clínic de Medicina i Dermatologia, Hospital Clínic, C/Villarroel 170, 08036 Barcelona, Catalonia, Spain; rcervera{at}clinic.ub.es

Abstract

Objective: We analysed the genetic polymorphisms in platelet glycoproteins (GP) Ib-α, Ia/IIa and IIb/IIIa and their correlation with the development of arterial thrombosis and preclinical arteriosclerosis in patients with antiphospholipid syndrome (APS) or with systemic lupus erythematosus (SLE).

Methods: We included 131 patients with APS (86 with primary APS and 45 with APS associated with SLE), 102 patients with SLE and 160 healthy controls. GP Ib-α VNTR polymorphism, GP Ia/IIa 807 C/T polymorphism and GP IIb/IIIa PlA1/2 polymorphism were determined by polymerase chain reaction. Thrombotic events were assessed clinically and confirmed by objective methods. The presence of preclinical arteriosclerosis was evaluated by a carotid ultrasound study in a subgroup of 70 patients with SLE measuring the intima-media wall thickness and the presence of arteriosclerotic plaque.

Results: A total of 50 episodes of arterial thrombosis in 36 patients with APS have been registered. We found a significant correlation between the 807 T/T genotype of GP Ia/IIa and arterial thrombosis (22% vs 7%, p = 0.04; OR 3.59, 95% CI 1.20 to 10.79). The VNTR Ib-α and P1A1/2 IIb/IIIa polymorphisms were not associated with arterial thrombosis in patients with APS when individually analysed. The coexistence of both 807 T and PlA2 alleles increased the arterial thrombosis risk (28% vs 7%, p = 0.005; OR 4.84, 95% CI 1.67 to 13.96). In patients with SLE, no relationship was found between the presence of carotid arteriosclerotic plaque and separate polymorphisms of platelet GP. The coexistence of alleles 807 T of GP Ia/IIa and PlA2 of GP IIb/IIIa was associated with the presence of carotid plaque (35% vs 4%, p = 0.002; OR 12.92, 95% CI 2.39 to 69.81).

Conclusions: The T/T genotype of 807 C/T polymorphism of GP Ia/IIa may be an additional risk for the development of arterial thrombosis in APS. The coexistence of both 807 T and PlA2 alleles increased the arterial thrombosis risk in patients with APS and preclinical arteriosclerosis in patients with SLE.

https://doi.org/10.1136/ard.2007.077321

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Funding: Supported in part by grants FIS 2000/1048, FIS 2002/0696, FIS 2002/0711 and FIS 2003/0280 from Fondo de Investigaciones Sanitarias (Instituto de Salud Carlos III, Spanish Ministry of Health) of Spain.

    • Competing interests: None.